Related Experiment Video
Updated: Apr 18, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
N,N-Dimethyl chitosan/heparin polyelectrolyte complex vehicle for efficient heparin delivery
Pedro V A Bueno1, Paulo R Souza1, Heveline D M Follmann1
1Grupo de Materiais Poliméricos e Compósitos, GMPC, Departamento de Química, Universidade Estadual de Maringá UEM, Av. Colombo 5790, CEP 87020-900 Maringá, Paraná, Brazil.
A novel N,N-dimethyl chitosan (DMC) and heparin (HP) polyelectrolyte complex (PEC) was developed for oral drug delivery. This heparin delivery system effectively protects the drug in the stomach and releases it in the intestines.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Heparin (HP) is a crucial anticoagulant drug with poor oral bioavailability.
- Developing effective oral delivery systems for heparin remains a significant challenge in pharmaceutical research.
- Chitosan derivatives offer potential for creating advanced drug delivery matrices.
Purpose of the Study:
- To prepare and characterize a novel polysaccharide-based device for oral heparin delivery.
- To evaluate the stability and release profile of heparin from the developed system under simulated physiological conditions.
- To assess the potential of the N,N-dimethyl chitosan/heparin complex as an oral drug carrier.
Main Methods:
- Synthesis and characterization of N,N-dimethyl chitosan (DMC) using (1)H NMR spectroscopy.
- Formation of a polyelectrolyte complex (PEC) between DMC and heparin (HP) at pH 3.0.
- Confirmation of PEC formation via FTIR, TGA/DTG, and WAXS.
- In vitro release studies of HP from PEC in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF).
Main Results:
- Successful preparation and confirmation of the DMC/HP polyelectrolyte complex.
- The PEC effectively protected heparin from degradation in simulated gastric fluid (SGF).
- Approximately 80% of loaded heparin was released from the PEC in simulated intestinal fluid (SIF).
Conclusions:
- The N,N-dimethyl chitosan/heparin (DMC/HP) polyelectrolyte complex shows significant potential as an oral drug carrier for heparin.
- The system demonstrates protective capabilities in the gastric environment and controlled release in the intestinal environment.
- Improved biological activity of heparin at physiological pH suggests suitability for oral administration.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Modified-Release Drug Delivery Systems: Rate-Programmed II

